An instrument to assess patient perceptions of satisfaction with acute migraine treatment (EXPERT study)

Headache

Volumn 51, Issue 4, 2011, Pages 590-601

  Lantéri Minet, Michel ^a,b   Massiou, Hélène ^c   Romatet, Sophie ^c   Barba, Adeline ^d   Lucas, Christian ^e   Allaf, Bashar ^d  

^a PASTEUR HOSPITAL   (France)

^b INSERM   (France)

^c Almirall ^*

^d CHU de Nice ^*  (France)

^e UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

General medical practice; Migraine; Satisfaction with treatment; Treatment effectiveness; Treatment evaluation; Triptans

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ERGOTAMINE TARTRATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; TRIPTAN DERIVATIVE;

ACUTE DISEASE; ADULT; ARTICLE; CONSULTATION; FEMALE; FRANCE; GENERAL PRACTITIONER; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MIGRAINE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; ANALGESICS; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SATISFACTION; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79953674192     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.01867.x     Document Type: Article

References (20)

1. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States. Epidemiology and patterns of health care use. Neurology. 2002;58:885-894.
2. Linde M, Dahlöf C. Attitudes and burden of disease among self-considered migraineurs - A nation-wide population-based survey in Sweden. Cephalalgia. 2004;24:455-465. (Pubitemid 38748027)
3. Patel NV, Bigal ME, Kolodner KB, Leotta C, Lafata JE, Lipton RB. Prevalence and impact of migraine and probable migraine in a health plan. Neurology. 2004;63:1432-1438. (Pubitemid 39426277)
4. Lantéri-Minet M, Valade D, Géraud G, Chautard MH, Lucas C. Migraine and probable migraine - Results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification. Cephalalgia. 2005;25:1146-1158.
5. Lucas C, Chaffaut C, Artaz MA, Lantéri-Minet M. FRAMIG 2000: Medical and therapeutic management of migraine in France. Cephalalgia. 2005;25:267-279.
6. Lantéri-Minet M. What do patients want from their acute migraine therapy? Eur Neurol. 2005;53(Suppl. 1):3-9.
7. Géraud G, Lantéri-Minet M, Lucas C, Valade D. French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther. 2004;26:1305-1318. (Pubitemid 39445352)
8. Ardilly P. Algorythmes de triage. In: Ardilly P, ed. Les Techniques De Sondage. Paris: Editions Technip; 1994:154-164 (in French).
9. International Headache Society, Headache Classification Subcommittee. The International Classification of Headache Disorders: 2nd Edition. Cephalalgia. 2004;24(Suppl. 1):9-160.
10. Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES). Diagnostic and therapeutic management of migraine in adults and children - Recommendations. 2002. Available at: http://www.anaes.fr/ANAES/ Publications.nsf (in French).
11. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36. (Pubitemid 12142173)
12. Direction de la Recherche, de l'Evaluation, des Etudes et des Statistiques (DREES). Bulletin no57, September 2003.
13. Henry P, Auray JP, Gaudin AF, et al. Prevalence and clinical characteristics of migraine in France. Neurology. 2002;59:232-237. (Pubitemid 34779183)
14. Lipton RB, Goadsby PJ, Sawyer JP, Blakeborough P, Stewart WF. Migraine: Diagnosis and assessment of disability. Rev Contemp Pharmacother. 2000;11:63-73. (Pubitemid 30137835)
15. Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF. Migraine, quality of life, and depression. Apopulation-based case-control study. Neurology. 2000;55:629-635.
16. Lantéri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and depression associated with migraine: Influence on migraine subjects' disability and quality of life, and acute migraine management. Pain. 2005;118:319-326. (Pubitemid 41752989)
17. Sheftell FD, Atlas SJ. Migraine and psychiatric comorbidity: From theory and hypotheses to clinical application. Headache. 2002;42:934-944. (Pubitemid 35285388)
18. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47:614-624. (Pubitemid 30261897)
19. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: A race against the development of cutaneous allodynia. Ann Neurol. 2004;55:19-26. (Pubitemid 38067357)
20. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT1B-1D agonists) in acute migraine treatment: A meta-analysis of 53 trials. Lancet. 2001;358:1668-1675. (Pubitemid 33124324)